CHADDS FORD, Pa. — The parent company of Endo Pharmaceuticals has changed its name, the company said.
Shareholders of Endo Pharmaceutical Holdings voted at the company's annual shareholder meeting Wednesday to change the company's name to Endo Health Solutions. The company said the name change would more accurately reflect its new business model, which aggregates four operating businesses into one enterprise.
"This important decision by our shareholders marks a milestone in our company's history and reinforces our position in the market as a leading provider of health solutions, merging healthcare information and a broader array of innovative treatment options that can ultimately lead to improved health outcomes for patients," Endo president and CEO Dave Holveck said.
The company's new business model will include four segments: medical device developer AMS; branded drug division Endo Pharmaceuticals; medical services, software, laboratory and medical records technology provider HealthTronics; and generic drug maker Qualitest.